Offerings (SEC Form D)
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
Offerings at a glance — 5 offerings, 5 filings (one row per SEC file number)
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|
| 021-350991 | Oct 15, 2019 EDGAR ↗ | Oct 15, 2019 D EDGAR ↗ | 0 | $22,556,011 | $22,556,011 | Other Health Care |
| 021-293234 | Aug 22, 2017 EDGAR ↗ | Aug 22, 2017 D EDGAR ↗ | 0 | $16,500,000 | $0 | Other Health Care |
| 021-229932 | Dec 11, 2014 EDGAR ↗ | Dec 11, 2014 D EDGAR ↗ | 0 | $26,000,000 | $0 | Other Health Care |
| 021-197620 | Jun 7, 2013 EDGAR ↗ | Jun 7, 2013 D EDGAR ↗ | 0 | $5,000,000 | $1,400,000 | Other Health Care |
| 021-188125 | Dec 11, 2012 EDGAR ↗ | Dec 11, 2012 D EDGAR ↗ | 0 | $2,000,000 | $1,593,787 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
Oct 15, 2019 D Other Health Care — $22,556,011 sold of $22,556,011 · 17 investors EDGAR ↗
| Filing | Form D filed Oct 15, 2019SEC file no. 021-350991 · accession 0001562489-19-000001 |
|---|
| Raise progress | $22,556,011 sold of $22,556,011 offered (100%) · $0 remaining · first sale Oct 4, 2019 |
|---|
| Filing timing | Date of first sale: Oct 4, 2019 · Form D filed: Oct 15, 2019 (11 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 2,577 days (7.1 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 17 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $26,543 |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
|---|
| Signed by | William McNally, SVP Finance (Oct 15, 2019) |
|---|
| Market context | Minimum investment: $26,543. Typical range for similar offerings: $10,000–$54,310.
Offering size: $22,556,011. Typical range: $829,831–$9,999,998.
Investors: 17. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Aug 22, 2017 D Other Health Care — $0 sold of $16,500,000 · 0 investors EDGAR ↗
| Filing | Form D filed Aug 22, 2017SEC file no. 021-293234 · accession 0001562489-17-000002 |
|---|
| Raise progress | $0 sold of $16,500,000 offered (0%) · $16,500,000 remaining |
|---|
| Filing timing | Date of first sale: Yet to occur · Form D filed: Aug 22, 2017 Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 0 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $15,000 |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | Manor Park Securities LLC — FINRA BrokerCheck CRD 169950 ↗ · associated broker-dealer: Manor Park Securities LLC (CRD 169950 ↗) Solicits in: MA |
|---|
| Money to insiders | Sales commissions: $0 (est.) · Finder's fees: $520,000 (est.) · Proceeds to officers, directors, promoters: $0 Issuer's note: See item 12. |
|---|
| Signed by | Paul Magelli, Chief Executive Officer (Aug 22, 2017) |
|---|
| Market context | Minimum investment: $15,000. Typical range for similar offerings: $10,000–$54,310.
Offering size: $16,500,000. Typical range: $829,831–$9,999,998.
Investors: 0. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Dec 11, 2014 D Other Health Care — $0 sold of $26,000,000 · 0 investors EDGAR ↗
| Filing | Form D filed Dec 11, 2014SEC file no. 021-229932 · accession 0001562489-14-000002 |
|---|
| Raise progress | $0 sold of $26,000,000 offered (0%) · $26,000,000 remaining · first sale Nov 26, 2014 |
|---|
| Filing timing | Date of first sale: Nov 26, 2014 · Form D filed: Dec 11, 2014 (15 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,350 days (11.9 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 0 total · includes 0 non-accredited investors |
|---|
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
|---|
| Minimum investment accepted | $25,000 |
|---|
| Securities offered | Equity |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: $1 - $1,000,000 (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $300,000,350,000 (est.) Issuer's note: Proceeds of the offering may be used as compensation for post-offering services and reimbursements for amounts owed |
|---|
| Signed by | Paul Magelli, Chief Executive Officer & President (Dec 11, 2014) |
|---|
| Market context | Minimum investment: $25,000. Typical range for similar offerings: $10,000–$54,310.
Offering size: $26,000,000. Typical range: $829,831–$9,999,998.
Investors: 0. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jun 7, 2013 D Other Health Care — $1,400,000 sold of $5,000,000 · 9 investors EDGAR ↗
| Filing | Form D filed Jun 7, 2013SEC file no. 021-197620 · accession 0001562489-13-000001 |
|---|
| Raise progress | $1,400,000 sold of $5,000,000 offered (28%) · $3,600,000 remaining · first sale May 31, 2013 |
|---|
| Filing timing | Date of first sale: May 31, 2013 · Form D filed: Jun 7, 2013 (7 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,894 days (13.4 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 9 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 505 (repealed in 2017) — offerings up to $5 million; older filings still carry this code; Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $10,000 |
|---|
| Securities offered | Equity; Debt |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: No Revenues (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $60,000 (est.) Issuer's note: Proceeds of the offering may be used as monthly compensation for Related Persons described herein for post-offering services in the amount stated above. |
|---|
| Signed by | Paul Magelli, Chief Executive Officer & President (Jun 6, 2013) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Dec 11, 2012 D Other Health Care — $1,593,787 sold of $2,000,000 · 17 investors EDGAR ↗
| Filing | Form D filed Dec 11, 2012SEC file no. 021-188125 · accession 0001562489-12-000002 |
|---|
| Raise progress | $1,593,787 sold of $2,000,000 offered (80%) · $406,213 remaining · first sale Apr 27, 2012 |
|---|
| Filing timing | Date of first sale: Apr 27, 2012 · Form D filed: Dec 11, 2012 (228 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 5,293 days (14.5 years) |
|---|
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 17 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c)) |
|---|
| Minimum investment accepted | $10,000 |
|---|
| Securities offered | Debt; Option, warrant or other right to acquire; Other: Convertible Promissory Notes |
|---|
| Entity details | Organized in DELAWARE · formed more than five years before filing · revenue range: No Revenues (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $350,000 (est.) Issuer's note: Reimbursement of pre-incorporation costs expended on behalf o issuer & compensation for post-incorporation services. |
|---|
| Signed by | Paul J. Magelli, Chief Executive Officer/Incorporator (Dec 10, 2012) |
|---|
| Market context | Not computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Oct 15, 2019. Industry as reported, by offering: All 5 offerings reported: Other Health Care (2012–2019).
Key people 19
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|
| AK Adam Koopersmith | Director | IL | Oct 15, 2019 on 1 of 5 filings listed on the latest filing | 9 other issuers |
| BM Blackford Middleton | Executive Officer | IL | Aug 22, 2017 → Oct 15, 2019 on 2 of 5 filings listed on the latest filing | — |
| JB James Bradley | Director | IL | Oct 15, 2019 on 1 of 5 filings listed on the latest filing | 1 other issuer |
| KJ Kenneth Jakobsen | Executive Officer | IL | Oct 15, 2019 on 1 of 5 filings listed on the latest filing | — |
| KH Kevin Hutchinson | Executive Officer, Director | IL | Oct 15, 2019 on 1 of 5 filings listed on the latest filing | 1 other issuer |
| KW Kevin Weinstein | Executive Officer | IL | Oct 15, 2019 on 1 of 5 filings listed on the latest filing | 2 other issuers |
| MA Mark Achler | Director | IL | Dec 11, 2014 → Oct 15, 2019 on 2 of 5 filings listed on the latest filing | 3 other issuers |
| ML Michael Liang | Director | IL | Aug 22, 2017 → Oct 15, 2019 on 2 of 5 filings listed on the latest filing | 12 other issuers |
| MO Michael Oltman | Executive Officer | IL | Aug 22, 2017 → Oct 15, 2019 on 2 of 5 filings listed on the latest filing | — |
| SL Sarah London | Director | IL | Oct 15, 2019 on 1 of 5 filings listed on the latest filing | — |
| WM William McNally | Executive Officer | IL | Oct 15, 2019 on 1 of 5 filings listed on the latest filing | — |
| BR Brad Ryan | Executive Officer | IL | Aug 22, 2017 on 1 of 5 filings not listed on the latest filing (Oct 15, 2019) | — |
| DS David Shreiner | Executive Officer | IL | Aug 22, 2017 on 1 of 5 filings not listed on the latest filing (Oct 15, 2019) | — |
| DT David Tuttle | Executive Officer | IL | Aug 22, 2017 on 1 of 5 filings not listed on the latest filing (Oct 15, 2019) | — |
| NL Noah Lewis | Director | IL | Aug 22, 2017 on 1 of 5 filings not listed on the latest filing (Oct 15, 2019) | — |
| PM Paul Magelli also filed as Paul J Magelli | Executive Officer, Director, Promoter | IL | Dec 11, 2012 → Aug 22, 2017 on 4 of 5 filings not listed on the latest filing (Oct 15, 2019) | 1 other issuer |
| AS Aaron Symanski | Executive Officer | IL | Jun 7, 2013 → Dec 11, 2014 on 2 of 5 filings not listed on the latest filing (Oct 15, 2019) | 1 other issuer |
| GP Geoff Phillips | Executive Officer, Director, Promoter | CT | Jun 7, 2013 → Dec 11, 2014 on 2 of 5 filings not listed on the latest filing (Oct 15, 2019) | — |
| RH Rick Halton | Executive Officer | Spain (as filed: U3) | Jun 7, 2013 on 1 of 5 filings not listed on the latest filing (Oct 15, 2019) | — |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗. Middle names: the SEC Form D data set (RELATEDPERSONS.tsv) repeats the previous person's middle name into later rows of the same filing; where that happened PartnerFacts shows the name without the repeated middle name and keeps the data-set spelling on record (Mark J Achler; Aaron J Symanski; Geoff J Phillips) — the filing on EDGAR is the source.
Connections
Other issuers listing the same people:
- Alto Neuroscience, Inc. — Michael Liang · latest filing Oct 27, 2025
- SNAK Venture Partners I LP — Adam Koopersmith · latest filing Aug 22, 2025
- KALDEROS, INC. — Aaron Symanski · latest filing Jan 3, 2025
- JumpCode Genomics, Inc. — Michael Liang · latest filing Aug 22, 2024
- InVivium Alto SPV, LLC — Michael Liang · latest filing Nov 13, 2023
- InVivium Capital, LP — Michael Liang · latest filing Jul 25, 2023
- Mingle Healthcare Solutions, Inc. — Adam Koopersmith · latest filing Mar 21, 2023
- Reach U.S., Inc. — Adam Koopersmith · latest filing Mar 18, 2022
- G2.com, Inc. — Adam Koopersmith · latest filing Jul 8, 2021
- rMark Bio, Inc. — Mark Achler · latest filing Oct 14, 2020
- KOLLECTIVE TECHNOLOGY, INC. — Adam Koopersmith · latest filing Aug 3, 2020
- DECIPHER BIOSCIENCES, INC. — Michael Liang · latest filing May 27, 2020
- Fibroblast, Inc. — Kevin Weinstein · latest filing Jan 15, 2020
- AIC Innovations Group, Inc. — Michael Liang · latest filing Aug 22, 2019
- Math Venture Partners II, L.P. — Mark Achler · latest filing Apr 19, 2019
- Illinois Emerging Technologies Fund III, LP — Michael Liang · latest filing Jan 11, 2018
- Beacon Solutions, Inc. — Adam Koopersmith · latest filing Dec 13, 2017
- ANALYTE HEALTH, INC. — Adam Koopersmith · latest filing Sep 29, 2017
- ANALYTE HEALTH, INC. — Kevin Weinstein · latest filing Sep 29, 2017
- Amphora Medical, Inc. — Michael Liang · latest filing Jul 27, 2017
- Insightra Medical, Inc. — Michael Liang · latest filing Aug 21, 2015
- Math Venture Partners, L.P. — Mark Achler · latest filing Apr 2, 2015
- Veniti, Inc. — Michael Liang · latest filing Jun 4, 2013
- PathCentral, Inc. — Michael Liang · latest filing Nov 26, 2012
- VELOCENT SYSTEMS INC — Paul Magelli · latest filing Oct 5, 2012
- SITTERCITY INC — Adam Koopersmith · latest filing Jul 6, 2011
- Firm58 Inc. — Adam Koopersmith · latest filing Jun 10, 2010
- Palyon Medical Corp — Michael Liang · latest filing Aug 10, 2009
- PREMATICS INC — James Bradley · latest filing Apr 7, 2009
- PREMATICS INC — Kevin Hutchinson · latest filing Apr 7, 2009
Shared address: this business address appears on filings for 5 other issuers. Stated as a count only (suite numbers ignored) — many addresses are shared office buildings or registered agents. As of Oct 23, 2026, 5:45 PM ET.
Address of record is shared by 6 issuers in SEC Form D filings (shared office, PartnerFacts count as of Oct 23, 2026, 5:45 PM ET) — not used to group this issuer.
Other offering types (Regulation A and Regulation Crowdfunding)
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Adviser registration (Form ADV)
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched APERVITA, INC..
Meta advertising
No Meta Pixel ids or Facebook / Instagram page links on file for APERVITA, INC. as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Public profiles
Public profiles official links and public statements, each with its source and date
No website or social profile named in APERVITA, INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #227,854 of 374,652 in line (14 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for IL yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
Corrections log
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.
Email me the full report
The complete public-record profile for APERVITA, INC., plus the weekly new-filings list.
What do you want to do?
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Request a correction
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).
Sponsor response
Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.
Claim this profile (sponsors)
Free. Get the "Claimed by sponsor" chip and a confirmed contact for corrections. Claiming never changes the public-record section.